WHO ICTRP trial
Long-term extension study of safety during treatment with tocilizumab (MRA) in…
EUCTR2005-002423-13-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2005-002423-13-DE |
|---|---|
| Public title | Long-term extension study of safety during treatment with tocilizumab (MRA) in patients completing treatment in WA17822 |
| Scientific title | Long-term extension study of safety during treatment with tocilizumab (MRA) in patients completing treatment in WA17822 |
| Primary sponsor | F. Hoffmann-La Roche Ltd |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Hungary;Slovakia;Germany;Bulgaria;Italy |
| Conditions | Rheumatoid arthritis |
| Interventions | Trade Name: RoActemra Product Name: MRA Product Code: RO4877533 Pharmaceutical Form: Concentrate for solution for infusion INN or Proposed INN: tocilizumab CAS Number: 375823-41-9 Current Sponsor code: R04877533 Other descriptive name: MRA… |
| Registration date | May 7, 2005 |
| Target size | 630 |
| Secondary IDs | WA18695 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: